Press Releases

Press Releases

Date Title Files

May 28, 2020

Dynavax to Present at the William Blair 40th Annual Growth Stock Conference

May 27, 2020

Dynavax Technologies Announces Closing of $80.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

May 21, 2020

Dynavax Technologies Announces Pricing of $70.0 Million Public Offering of Common Stock

May 21, 2020

Dynavax Technologies Announces Proposed Public Offering of Common Stock

May 07, 2020

Dynavax Announces First Quarter 2020 Financial Results

Apr 28, 2020

Dynavax Reports Interim Analysis of Ongoing Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodialysis

Apr 23, 2020

Dynavax to Report First Quarter 2020 Financial Results and Host Conference Call on May 7, 2020

Apr 22, 2020

Valneva and Dynavax Announce Collaboration to Advance Vaccine Development for COVID-19

Apr 16, 2020

Dynavax and Sinovac Announce Collaboration to Develop a Coronavirus (COVID-19) Vaccine

Apr 08, 2020

Dynavax Donates 10,000 Doses of HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted] Vaccine to Emergency Healthcare Providers and Hospital Staff to Protect Against Hepatitis B Infections Amidst COVID-19 Pandemic